In three independent publicly available microarray datasets of ovarian cancer patients [20–22] we found a significant correlation between higher levels of PDGFRβ and VEGFR2 gene expression and reduced overall survival (Figure 3). The gene discussed is PDGFRB; the disease is ovarian carcinoma.